Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Autoimmunity Reviews
|
February 24, 2009
Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
A Kuhn, E Kuehn, A M Meuth, et al.
Cancer Research
|
April 1, 1995
Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene
J Groden, G Joslyn, W Samowitz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
November 27, 2007
[Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype]
R Stöhr, J W F Catto, A Azzouzi, et al.
Urology
|
December 15, 2004
Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study
I Rehman, A R Azzouzi, J W F Catto, et al.
Oncogene
|
March 29, 2000
Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene
M Kanamori, H Kon, T Nobukuni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 21, 2010
Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
D Bein, E Kuehn, A M Meuth, et al.
The Journal of Pathology
|
April 28, 2006
Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma
D Dhawan, F C Hamdy, I Rehman, et al.
The British Journal of Dermatology
|
August 29, 2009
Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus
V Schmitt, A M Meuth, S Amler, et al.
British Journal of Cancer
|
November 14, 2013
HDAC inhibitor confers radiosensitivity to prostate stem-like cells
F M Frame, D Pellacani, A T Collins, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]
M Burger, J Catto, J van Oers, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Autoimmunity Reviews
|
February 24, 2009
Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
A Kuhn, E Kuehn, A M Meuth, et al.
Cancer Research
|
April 1, 1995
Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene
J Groden, G Joslyn, W Samowitz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
November 27, 2007
[Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype]
R Stöhr, J W F Catto, A Azzouzi, et al.
Urology
|
December 15, 2004
Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study
I Rehman, A R Azzouzi, J W F Catto, et al.
Oncogene
|
March 29, 2000
Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene
M Kanamori, H Kon, T Nobukuni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 21, 2010
Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
D Bein, E Kuehn, A M Meuth, et al.
The Journal of Pathology
|
April 28, 2006
Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma
D Dhawan, F C Hamdy, I Rehman, et al.
The British Journal of Dermatology
|
August 29, 2009
Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus
V Schmitt, A M Meuth, S Amler, et al.
British Journal of Cancer
|
November 14, 2013
HDAC inhibitor confers radiosensitivity to prostate stem-like cells
F M Frame, D Pellacani, A T Collins, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]
M Burger, J Catto, J van Oers, et al.
Page
of 9